Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul-Sep;37(3):99-100.
doi: 10.1016/j.hipert.2020.04.002. Epub 2020 Apr 16.

[Renin-angiotensin system blockers and COVID-19 infection]

[Article in Spanish]
L M Ruilope  1 , J A Garcia Donaire  2 , A de la Sierra  3
Affiliations
Editorial

[Renin-angiotensin system blockers and COVID-19 infection]

[Article in Spanish]
L M Ruilope et al. Hipertens Riesgo Vasc. 2020 Jul-Sep.
No abstract available

PubMed Disclaimer

References

    1. Somerstein R. Preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ. 2020;368:m810. https://www.bmj.com/content/368/bmj.m810/rr-2 - PubMed
    1. Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet. 2020;8:e21. doi: 10.1016/S2213-2600(20)30116-8. - DOI - PMC - PubMed
    1. Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020 doi: 10.1002/ddr.21656. - DOI - PMC - PubMed
    1. Danser A.H.J., Epstein M., Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic. At present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020;75 doi: 10.1161/HYPERTENSIONAHA.120.15082. - DOI - PMC - PubMed
    1. Bavishi C., Maddox T.M., Messerli F.H. Coronavirus Disease (COVID-19) Infection and Renin Angiotensin System Blockers. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1282. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources